Literature DB >> 11051455

Distribution of alphavbeta3, alphavbeta5 integrins and the integrin associated protein--IAP (CD47) in human glomerular diseases.

Z Hafdi1, P Lesavre, M Nejjari, L Halbwachs-Mecarelli, D Droz, L H Noël.   

Abstract

The alphav integrins present on the membrane of numerous cells, mediate attachment to matrix proteins, cell proliferation, migration and survival. We studied the expression of alphav integrinis and CD47 (a beta3 chain integrin associated protein) in various forms of glomerulonephritis (GN) characterized by mesangial proliferation and/or increased mesangial matrix. In normal glomeruli, epithelial cells expressed alphavbeta3, alphavbeta5 and CD47; endothelial cells expressed alpha5beta1 and CD47; mesangial cells expressed alphavbeta5, CD47, and to a less extent alphavbeta3. In acute post infectious GN (APIGN), membrano-proliferative GN (MPGN) and diabetic nephropathy(DN), we observed that the beta3 chain, normally expressed by mesangial cells, was not detectable in the mesangium while its expression by epithelial cells was not modified. Parallel to the disappearance of alphavbeta3, the CD47 expression was decreased on the mesangial cells in MPGN, APIGN and DN. The expression of alphavbeta5 was clearly increased on podocytes and on proliferating mesangial cells in APIGN. By contrast, the mesangial expression of alphavbeta was normal or decreased in DN. The alpha5 chain of integrin, absent on normal mesangial cell, was expressed on proliferating mesangial cells in MPGN and APIGN. Thus, we observed modifications of alphavbeta3 and alphavbeta5 expression during human GN. The modulations of alphavbeta3 and alphavbeta5 expression differed according to the different glomerular cell types and were not parallel in glomerular cells: alphavbeta3 was decreased (and alphavbeta5 unchanged) on proliferating mesangial cells and alphavbeta5 was increased (and alphavbeta3 unchanged) in podocytes. This may reflect the existence of two distinct regulatory pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11051455     DOI: 10.3109/15419060009040302

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  10 in total

1.  Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease.

Authors:  Jesús M López-Guisa; Allen C Rassa; Xiaohe Cai; Sarah J Collins; Allison A Eddy
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

Review 2.  The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Pediatr Nephrol       Date:  2018-11-03       Impact factor: 3.714

3.  Anti-inflammatory effects of alphav integrin antagonism in acute kidney allograft rejection.

Authors:  Jens Bedke; Eva Kiss; Carl-Ludwig Behnes; Zoran V Popovic; Markus Heuser; Tomislav Stojanovic; Tjeerd Sijmonsma; Peter Huber; Sophie Domhan; Stefan Muschal; Amir Abdollahi; Norbert Gretz; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2007-08-16       Impact factor: 4.307

Review 4.  Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management.

Authors:  Natasha M Rogers; Mingyi Yao; Enrico M Novelli; Angus W Thomson; David D Roberts; Jeffrey S Isenberg
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

5.  Inhibition of αvβ5 Integrin Attenuates Vascular Permeability and Protects against Renal Ischemia-Reperfusion Injury.

Authors:  Amy McCurley; Stella Alimperti; Silvia B Campos-Bilderback; Ruben M Sandoval; Jenna E Calvino; Taylor L Reynolds; Catherine Quigley; Joshua W Mugford; William J Polacheck; Ivan G Gomez; Jennifer Dovey; Graham Marsh; Angela Huang; Fang Qian; Paul H Weinreb; Brian M Dolinski; Shaun Moore; Jeremy S Duffield; Christopher S Chen; Bruce A Molitoris; Shelia M Violette; Michael A Crackower
Journal:  J Am Soc Nephrol       Date:  2017-01-06       Impact factor: 10.121

Review 6.  Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.

Authors:  Joanne E Murphy-Ullrich; Mark J Suto
Journal:  Matrix Biol       Date:  2017-12-27       Impact factor: 11.583

7.  CD47 (Cluster of Differentiation 47).

Authors:  Sukhbir Kaur; Jeffrey S Isenberg; David D Roberts
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2021

8.  Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.

Authors:  Delma Veron; Guillermo Villegas; Pardeep Kumar Aggarwal; Claudia Bertuccio; Juan Jimenez; Heino Velazquez; Kimberly Reidy; Dale R Abrahamson; Gilbert Moeckel; Michael Kashgarian; Alda Tufro
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

9.  Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage.

Authors:  Paolo Durigutto; Daniele Sblattero; Stefania Biffi; Luca De Maso; Chiara Garrovo; Gabriele Baj; Federico Colombo; Fabio Fischetti; Antonio F Di Naro; Francesco Tedesco; Paolo Macor
Journal:  Front Immunol       Date:  2017-09-06       Impact factor: 7.561

10.  Spatially Resolved Transcriptomes of Mammalian Kidneys Illustrate the Molecular Complexity and Interactions of Functional Nephron Segments.

Authors:  Arti M Raghubar; Duy T Pham; Xiao Tan; Laura F Grice; Joanna Crawford; Pui Yeng Lam; Stacey B Andersen; Sohye Yoon; Siok Min Teoh; Nicholas A Matigian; Anne Stewart; Leo Francis; Monica S Y Ng; Helen G Healy; Alexander N Combes; Andrew J Kassianos; Quan Nguyen; Andrew J Mallett
Journal:  Front Med (Lausanne)       Date:  2022-07-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.